RA Capital Healthcare Fund LP, 10% Owner at Fulcrum Therapeutics, Inc. (FULC), bought 361,406 shares at $7.80 ($2.6M) on 2023-01-04, disclosed to the SEC on 2023-01-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.03 | 122,334 | $860K | 32.7% |
| 2 | $7.03 | 122,334 | $860K | 32.7% |
| 3 | $7.80 | 58,369 | $455K | 17.3% |
| 4 | $7.80 | 58,369 | $455K | 17.3% |
| Total | $7.28 avg | 361,406 | $2.6M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |